argenx to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024
2024年5月2日 - 2:00PM
May 2, 2024Amsterdam,
the Netherlands – argenx (Euronext & Nasdaq: ARGX), a
global immunology company committed to improving the lives of
people suffering from severe autoimmune diseases, today announced
that it will host a conference call and audio webcast on Thursday,
May 9, 2024 at 2:30 PM CET (8:30 AM ET) to discuss its first
quarter 2024 financial results and provide a business update.
A webcast of the live call may be accessed on
the Investors section of the argenx website at
argenx.com/investors. A replay of the webcast will be available on
the argenx website for approximately one year following the
presentation.
Dial-in numbers:
Belgium 32 800 50
201France
33 800
943355Netherlands
31 20 795 1090United Kingdom 44 800 358 0970United
States 1 800 715
9871Japan
81 3 4578
9081Switzerland 41
43 210 11 32
Use the access code 1231519 to join the call.
Please dial in 15 minutes prior to the live call.
About argenx
argenx is a global immunology company committed
to improving the lives of people suffering from severe autoimmune
diseases. Partnering with leading academic researchers through its
Immunology Innovation Program (IIP), argenx aims to translate
immunology breakthroughs into a world-class portfolio of novel
antibody-based medicines. argenx developed and is commercializing
the first approved neonatal Fc receptor (FcRn) blocker in the U.S.,
Japan, Israel, the EU, the UK, Canada and China. The Company is
evaluating efgartigimod in multiple serious autoimmune diseases and
advancing several earlier stage experimental medicines within its
therapeutic franchises. For more information, visit www.argenx.com
and follow us on LinkedIn, X/Twitter, Instagram, Facebook, and
YouTube.
For further information, please
contact:
Media:
Ben PetokBPetok@argenx.com
Investors:
Alexandra Roy (US)aroy@argenx.com
Lynn Elton (EU)lelton@argenx.com
Argen X (EU:ARGX)
過去 株価チャート
から 10 2024 まで 11 2024
Argen X (EU:ARGX)
過去 株価チャート
から 11 2023 まで 11 2024
